Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.
BriefNYTimes Health
Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
BriefNYTimes Health
Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.